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Abstract
We report on the activities of the 2015 edition of the BioHackathon, an
annual event that brings together researchers and developers from around
the world to develop tools and technologies that promote the reusability of
biological data. We discuss issues surrounding the representation,
publication, integration, mining and reuse of biological data and metadata
across a wide range of biomedical data types of relevance for the life
sciences, including chemistry, genotypes and phenotypes, orthology and
phylogeny, proteomics, genomics, glycomics, and metabolomics. We
describe our progress to address ongoing challenges to the reusability and
reproducibility of research results, and identify outstanding issues that
continue to impede the progress of bioinformatics research. We share our
perspective on the state of the art, continued challenges, and goals for
future research and development for the life sciences Semantic Web.
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Abbreviations
Miscellaneous
API, Application Programming Interface; BH15, BioHackathon 2015; CUI, Concept Unique Identifier; CV, Controlled
Vocabulary; DOID, DO IDentifier; DPA, Disease-Phenotype
Association; EHR, Electronic Health Records; FAIR, Findable,
Accessible, Interoperable and Reusable; GDA, Gene-Disease
Association; GPM, General Process Model; LIMS, Laboratory Information Management System; MSEA, Metabolite Set Enrichment Analysis; ORCID, Open Researcher and
Contributor ID; NLP, Natural Language Processing; NMR,
Nuclear Magnetic Resonance; VG, genomic Variation Graph.

Ontologies and vocabularies
BAO, BioAssay Ontology; CDAO, Comparative Data Analysis Ontology; ChEBI, Chemical Entities of Biological Interest; CHEMINF, CHEMical INFormation ontology; DC, DCT,
Dublin Core, Dublin Core Terms; DO, Disease Ontology;
EFO, Experimental Factor Ontology; EpSO, Epilepsy and Seizure Ontology; ERO, Eagle-i Resource Ontology; EXACT,
Experiment ACTions ontology; EXPO, Ontology of scientific
experiments; FMA, Foundational Model of Anatomy; FOAF,
Friend Of A Friend; GO, Gene Ontology; HPO, Human Phenotype Ontology; IAO, Information Artifact Ontology; LABORS,
LABoratory Ontology for Robot Scientists; MOD, Metadata for
Ontology Description; MP, Mammalian Phenotype ontology;
OA, Open Annotation ontology; OBAN, Ontology of Biomedical AssociatioN; OBI, Ontology for Biomedical Investigations; OMV, Ontology Metadata Vocabulary; ORDO, Orphanet
Rare Disease Ontology; ORTH, ORTHology ontology; PATO,
Phenotypic quality ontology; PICO, Patient Intervention
Comparison Outcome; PIERO, Partial Information of chemical
transformation; RO, Relations Ontology; SIO, Semanticscience
Integrated Ontology; SIRO, Sample, Instrument, Reagent,
Objective; SMART Protocols, SeMAntic RepresenTation for
experimental protocols; UMLS, Unified Medical Language
System.
Organizations
BTMG, Biomedical Text Mining Group at the NIH; DBCLS,
Database Center for Life Science; EBI, European Bioinformatics Institute; GA4GH, Global Alliance for Genomics and
Health; HGNC, HUGO Gene Nomenclature Committee; jPOST,
Japan Proteome Standard Repository/Database; LOV, Linked
Open Vocabularies; NBDC, National Bioscience Database
Center; NCBI, National Center for Biotechnology Information;
NCBO, National Center for Biomedical Ontology; NESCent,
National Evolutionary Synthesis Center; NIH, National Institutes of Health; OBO Foundry, Open Biomedical Ontologies
Foundry; Open PHACTS, Open Pharmacological Concept
Triple Store; PDBj, Protein Database Japan; RDA, Research
Data Alliance.
Project
CWL, Common Workflow Language; DisGeNET, Disease
Gene Network; GEO, Gene Expression Omnibus; HUPOPSI, Human Proteome Organization Proteomics Standards
Initiative; KEGG-OC, Kyoto Encyclopedia of Genes and

Genomes – Orthologous Clusters; LSDB Archive, Life Science
Database Archive; MBGD, Microbial Genome Database; MeKO,
Metabolite profiling database for Knock-Out mutants in Arabidopsis; OLS, Ontology Lookup Service; OMA, Orthologous
MAtrix; OMIM, Online Mendelian Inheritance in Man; ORKA,
Open, Reusable Knowledge graph Annotator; PASSEL, Peptide
AtlaS SRM Experiment Library; PMR, Plant and Microbial
Metabolomics Resource; PRIDE, PRoteomics IDEntifications
database ; QfO, Quest for Orthologs; SADI, Semantic Automated Discover and Integration; SIDER, SIDe Effect Resource;
SWIT, Semantic Web Integration Tool.

Technologies
BED, Browser Extensible Data; HPC, High Performance Computing; HTTP, HyperText Transfer Protocol; JSON, JavaScript
Object Notation; JSON-LD, JSON – Linked Data; LOD, Linked
Open Data; OWL, Web Ontology Language; RDF, Resource
Description Framework; RDFa, RDF in Attributes; RML, RDF
Modeling Language; SAM/BAM, Sequence Alignment/Map,
Binary Alignment/Map; SHA, Secure Hash Algorithm; SPARQL,
SPARQL Protocol and RDF Query Language; TPF, Triple Pattern Fragments1; URI, Universal Resource Identifier; VCF,
Variant Call Format; YAML, YAML Ain’t Markup Language;
XML, eXtensible Markup Language.

Background
The past few years have yielded considerable progress in the
development and application of fundamental digital technologies
that support research in the life sciences2, including ontologies
and Linked Open Data (LOD), semantic web services, natural
language processing, and tooling for workflows and virtualization. While these technologies are useful for life sciences research,
key to their long-term success lies in community agreements
that foster standardization and interoperability2. In an effort to
coordinate the social and technological aspects of in silico life
sciences research, the authors convened at the 2015 edition of
the BioHackathon (BH15), an event that aims to create a highly
collaborative environment to explore, evaluate, and implement
solutions to the problems of data publication, integration, and
reuse3–6. A hackathon is a type of software development lifecycle
model featuring problem-focused development via intensive, time-limited, self-organized group activities, typically
involving programmers and various types of collaborators7.
The hackathon methodology has been shown to be productive in a variety of biomedical fields, including rehabilitative
healthcare8, biological data science9, neuroscience10, computeraided differential diagnosis11, stroke detection12, standards
specification in systems and synthetic biology13, data science for
knowledge discovery in medicine14, medical device innovation15,
enrichment of biodiversity data16, and teaching genomics17.
BH15 was held in Nagasaki, Japan, over the period of
September 14th to 18th 2015, and was hosted by the National
Bioscience Database Center (NBDC,18) and the Database
Center for Life Science (DBCLS,19) to promote interoperability of life sciences databases in Japan. Researchers and developers from around the world participated by invitation. BH15 was
preceded by a public symposium featuring new research and
updates from the participants. BH15 involved 80 individuals
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from 12 countries and a wide variety of backgrounds, including
computer programmers, bioinformaticians, biocurators, ontologists, biological scientists, systems biologists, data scientists, and
linguists.
Here, we present selected outcomes from BH15, self-organized
by the participants in projects around different topics, which
we discuss in the following sections. At the highest level, the
contours of these topics are, broadly, i) life sciences data,
including genotypes and phenotypes, orthology and phylogeny,
proteomics, metabolomics, and biochemical molecular;
and ii) research methods, i.e. the technologies that support
in silico analysis in the life sciences, including data retrieval
and querying, natural language processing, reproducibility,
and semantic metadata. Under these broad topics, we identify
various themes within which specific activities took place.
These topics and themes are illustrated in Figure 1. The activities and their scopes were identified by the participants through
self-organization following Open Space technology20. As such,
the commitment of the participants to any particular activity was somewhat free-wheeling, and so we report the outcomes collectively, rather than subdivided by participant teams.
The results of the work reported here are relevant both to evaluate the current state of the relevant technologies and problem
areas in the life sciences, and to help the field understand the
potential and problems of future research and development
efforts.

Life sciences data
Genotypes and phenotypes
Variation graph construction. In the context of the Global Alliance for Genomics and Health (GA4GH,21) there is a

challenge to build genomic variation graphs (VG). A genomic
variation graph represents all “common” genetic variation, providing a means to stably name and canonically identify each
variant. At BH15, we modeled such graphs using RDF semantics.
Taking the 1000 Genomes project phase 3 Variant Call Format (VCF) files and the GRCh37 human reference genome we
built a variant graph using the VG tool22. Such a VG graph corresponds to just fewer than 2 billion triples. It was loaded
inside 67 minutes on a server from 2013 that had 64 AMD
X86_64 cores, 256 GB ram, and 3 TB of consumer-quality SSD
storage without specific tuning. The SPARQL database disk
footprint with indexes was 49 GB, i.e. double the disk space
consumed by the raw VG tool files. This shows that a modern
SPARQL database does not require exorbitant resources to be
able to index and load a variant graph of interest to the medical
community. We also demonstrated that a number of queries on the
graph executed within reasonable times. This work was contributed to the VG development team and incorporated into
the VG release 1.4.0. At BH15, the standard API developed
by the core API team of the GA4GH was implemented as a
service running on top of a SPARQL endpoint.
Variant call transformation. VCF is a standard for text files
that store gene sequence variations and is used for large-scale
genotyping and DNA sequencing projects. Converting a single high-throughput sequence dataset, e.g. a VCF file but more
so a very large database such as the Ensembl Variation Database, into RDF results in a number of triples that may be
unmanageable for a small bioinformatics lab, even if backed
by current hardware. However, data can also be considered in a more dynamic way, if we abstract the concept of data
generation to, for instance, some bioinformatics analysis or

Figure 1. Main themes and topics of the BioHackathon 2015.
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pipeline, where new data can be generated on the fly as a result
of some computation over existing information or files. To
this end we prototyped a real-time system to transform VCF
into RDF and query it by SPARQL. With JRuby we could use
the original samtools/htsjdk libraries for manipulating VCF,
BED, SAM/BAM files. With this approach, we could quickly
prototype our solution and defer the development of proper
Java libraries sharable by alternative approaches and/or
applications. Our approach allows generating virtual endpoints over multiple VCF files, combining the simplicity of
native file formats with the power of the SPARQL language,
significantly improving the way we link and query heterogeneous
information. An implementation of such a system was conceived during the 1st RDF summit in 2014 at the DBCLS in
Tokyo and further developed during BH15. The system23 was
based on de facto standard frameworks, such as Ruby RDF24 and
OpenSesame25, which facilitate the generation and transformation of RDF based data and the processing of SPARQL
algebra and queries.
Phenotype ontology translation. Precision medicine aims to provide patient-tailored diagnostics, prognostics, treatments, and
prevention. Part of the strategy to precision medicine involves
more precise clinical phenotyping. The Human Phenotype Ontology (HPO) is an ontology of abnormal phenotypes associated
with human disease26. Originally aimed to describe Mendelian
genetic diseases, it has since been expanded to cover phenotypes associated with rare and common diseases. The availability of phenotype terms expressed in the Japanese language is
key to its application in text mining Electronic Health Records
(EHR) in Japan.
The development project of HPO-Japanese was initiated prior to
BH15 in cooperation with the HPO teams (Dr. Peter Robinson,
Dr. Melissa Haendel, Dr. Nicole Vasilevsky, and Dr. Tudor
Groza). We translated English terms into Japanese by exact
matches to existing English-Japanese dictionaries, including the
Elements of Morphology – Standard Terminology (Japanese
ed.), the Japanese Association of Medical Sciences Medical
Term Dictionary, the Life Science Dictionary (LSD), and general dictionaries. The total number of terms translated is 11,425.
Elements of Morphology – Standard Terminology (Japanese
ed.) covers ~400 terms (3.5%), the Japanese Association of
Medical Sciences Medical Term Dictionary covers 1,807 terms
(15.8%). The remaining terms need to be curated by experts.
We are now compiling several translated terms as curated HPOJapanese. Once completed, HPO-Japanese will be open and
available so that precise and standardized phenotyping can be
undertaken using Japanese EHR text and which can be directly
linked to the international resources and research systems through
HPO identifiers.

Orthology and phylogeny
Orthology ontology development and application. Orthologs
are defined as genes derived from a common ancestral gene by
speciation. Orthology information can play a central role in predicting gene function in newly sequenced genomes and can also
help unravel the evolutionary history of genes and organisms.

Orthology resources have been represented in a variety of formats, including the OrthoXML27 that is used by several orthology databases such as InParanoid28, Orthologous MAtrix
(OMA,29), and TreeFam30. The interest in exchanging orthology data with other communities has provided the impetus
for research on applying the Semantic Web and using common ontologies for making the meaning of the content explicit.
Thus, on the basis of previous studies on the semantic representation of orthology31,32, we made efforts during BH15 towards
semantic standardization of orthology content33.
We developed the Orthology Ontology (ORTH,34 and35) to
capture essential concepts pertaining to orthology, including clusters of orthologs derived from speciation events. ORTH
was designed following best practices in ontology engineering,
i.e., reusing related ontologies such as the Semanticscience Integrated Ontology (SIO,36), the Relations Ontology (RO,37), and
the Comparative Data Analysis Ontology (CDAO,38). We used
the Semantic Web Integration Tool (SWIT,39 and40), a generic tool
for generating semantic repositories from relational databases
and XML sources, to convert InParanoid, OMA, and TreeFam
datasets in OrthoXML format into RDF. More details and sample queries for the datasets using ORTH are on the source code
repository41,42.
Although the standard mapping and transformation by SWIT
was largely able to transform the content of the three databases,
though a few resource-specific rules were necessary because:
(1) OrthoXML offers generic tags that are used by orthology databases in a heterogeneous way, e.g. for describing the
taxonomic range of a cluster of orthologs; and (2) different
orthology resources use identifiers of genes or proteins from different databases, so the corresponding prefixes for URIs had to
be adapted. The next steps include: (1) evaluation of the results
by the Quest for Orthologs (QfO,43) community, which could
lead to the development of a QfO semantic infrastructure for
sharing orthology resources; (2) examining the interoperability
of semantic orthology datasets using additional databases such
as UniProt44, KEGG OC45, and the Microbial Genome Database (MBGD,46); and (3) developing applications and tools for
comparative analysis of genomes/proteomes utilizing the ORTH.
Molecular evolutionary process calibration. Not only qualitative but also quantitative representation of evolutionary events,
i.e. on a time axis, among organisms is important for evolutionary biology. However, the adoption of Semantic Web technologies is lagging behind in domains of the biological sciences
outside of the conventional scope of BH15. For example, in
recent years several hackathons and other meetings have been
held to address challenges of data mobilization47 and integration
in phyloinformatics48,49 and biodiversity informatics16 that uncovered a paucity of web services that deliver ontologized, or even
machine-readable, data on fossil specimens. Although expected
waiting times between speciation events can be modeled50,
fossils are needed for calibrating phylogenies to absolute time
axes49,51,52, e.g. to detect nucleotide substitution rate shifts coinciding with evolutionary events such as speciations, which generate
orthology, and gene duplications, which generate paralogy.
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Recently, a working group at the National Evolutionary Synthesis Center (NESCent,53) initiated a project to address this54
and to establish a database of reference fossils with a web service API55. To evaluate whether this new resource can indeed
be usefully applied in the analysis of molecular data we
developed a proof-of-concept pipeline55 (based on Bio::Phylo56
and SUPERSMART57) that includes a reconciliation between
fossil taxa from the FossilCalibrations database and extant
taxa from in the TreeFam orthology database. The steps are as
follows:
1. Download a data dump release from TreeFam.
2. F
 or each TreeFam gene family, fetch fossils from
FossilCalibrations through the API. This was done by
querying for the taxonomic names, e.g. “Mammalia”, that
are applied to internal node labels in gene family trees.
3. A
 pply the fossil ages as calibration points for a
penalized likelihood analysis using r8s58.
4. U
 sing the produced ‘ratogram’ (a phylogenetic tree
whose branch lengths are proportional to inferred substitution rates, one of the results produced by the r8s
analysis), calculate the substitution rate as a function of
time since the most recent gene duplication event.

The rationale for this pipeline was that the general model of
gene duplication followed by neo- or subfunctionalization59
suggests that reconstructed substitution rates (which are
retrospective, and based on accumulated fixed mutations)
should be elevated in novel gene copies that are either under
relaxed or under directional selective pressure. Hence, we
would expect to see elevated substitution rates following a
duplication event, which should taper off over time. Given that
baseline substitution rates differ between lineages we performed
an assessment of whether this prediction could be detected
confined to a single lineage, that of C. elegans. Figure 2 suggests that this is indeed the case (this is in essence a different
way of obtaining, roughly, some of the findings of60). As a proof
of concept to test whether it is possible to include fossil data
from this new resource we conclude that this is indeed possible,
but we note several drawbacks:
• T
 he FossilCalibrations database makes its data available as simple JSON. This is convenient for programmers
but it also means that certain concepts used in the
JSON are ambiguous as they are not linked to any
controlled vocabulary or ontology.
• T
 he distinction between stem and crown fossils is made
using magic numbers whose values and their meanings are

Figure 2. Substitution rates as a function of evolutionary distance since the age of the most recent gene duplication observed in
Caenorhabditis genomes.
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poorly documented (we could only discover their semantics
by inspecting the source code of FossilCalibrations).
• S
 ome of the taxon names used by FossilCalibrations are
not scientific names from any explicitly identified taxonomy. For example, some fossil calibration points have
names such as “Chimpanzee-Human”, or “Humanity”.
Such names are difficult to resolve using taxonomic name
resolution services.
• T
 here are large biases in taxon sampling in the database. In fossil databases this is nearly inevitable as some
taxa fossilize much better than others, but even where
a relatively rich fossil record is known to exist, e.g. in
the sea urchins (Takeshi Kawashima, pers. comm.), no
records were available in the database.
The first three drawbacks we identified can all be traced back
to poorly defined semantics, which we therefore characterize as the key current issue in LOD representation of fossil specimens. To fill this gap, firstly we need to semantically
curate FossilCalibrations data manually, which of course
may take time, then export curated information in RDF so
that analyses proposed in this section can be integrated in the
automated pipeline.

Proteomics
Protein semantic representation. Many datasets on the Semantic Web are available as RDF, but often lack the explicit modeltheoretic semantics provided by languages such as OWL. For
complex datasets, the additional semantics of OWL, which
includes assertions of disjointness, i.e. the explicit semantic distinction between classes and their instances, and axioms restricting the use of classes and object properties, may be
particularly beneficial. The main limitation of languages such
as OWL is that querying them is often highly computationally intensive and therefore not feasible for large datasets. Our
aim was to evaluate how well formal languages like OWL
scale in representing very large datasets. We chose the UniProt
database44, as it currently constitutes one of the larger RDF
datasets, is used throughout biology, and has rigorous quality
checks. Our aim was to find a representation of proteins and their
functions using OWL. As automated reasoning over OWL
knowledge bases is highly complex (2-NEXPTIME complete), we limited ourselves to the OWL 2 EL profile. However,
widely used ontology design patterns for representing functions
are not expressible in OWL 2 EL, as certain types of restrictions (in particular universal quantification) do not fall within
the OWL 2 EL expressivity. As a consequence of these
limitations, we decided to develop a novel representation pattern for asserting that proteins have a function that would fall
in OWL 2 EL and would enable us to convert all of UniProtKB
into OWL (though for testing purposes we converted only a
subset on the order of 105 OWL axioms). Specifically, given
proteins XYZ, we generate the following classes:
• C
 lass XYZ (instances of this class are individual proteins)
• C
 lass XYZ_all (instances are the sets of all XYZ proteins in the universe; intuitively, only one instance of this
class can ever exist)

• C
 lass XYZ_isoform for all isoforms of XYZ
• C
 lass XYZ_generic (the 'generic' form of the protein,
i.e., a group of orthologous proteins)
• W
 e also generate the following axioms (here expressed in
Manchester OWL Syntax):
• X
 YZ SubClassOf: XYZ_generic
• X
 YZ_isoform SubClassOf: XYZ
• X
 YZ_isoform SubClassOf: isoform-of some XYZ
• X
 YZ SubClassOf: member-of some XYZ_all
• X
 YZ_all SubClassOf: { xyz } i.e., XYZ_all is a singleton class, and lower-case xyz is a new constant symbol
that is newly introduced for each axiom of that type
• X
 YZ_all SubClassOf: has-member only XYZ (XYZ_all
is homogenic)
Of these axioms, only the last axiom (XYZ_all is homogenic)
is not expressible in OWL 2 EL, while all other axioms can be
expressed in the OWL 2 EL profile. We have converted several types of proteins from UniProtKB using this approach
and evaluated queries and query time. However, a thorough
analysis on how well this approach scales to ontologies of
the size of UniProtKB is left for future work. The source
code developed for this project is available at our source code
repository61,62.
Proteome assay annotation. In proteomics, expressed proteins
are usually identified by mass spectrometry. In most
common workflows, proteins are digested into peptides with a
protease. The peptides are ionized and then fragmented. Their
precursor mass-to-charge ratios and fragment ion spectra are
experimentally measured and compared with theoretical masses
and fragmentation patterns of peptides calculated from a protein database. Information about experimental protocols and
data analysis methods is thus important for understanding the
raw and processed data. An identified protein list has substantial amounts of metadata such as labels used for quantification,
e.g. iTRAQ,63, or SILAC,64, protease used for protein digestion (most commonly trypsin), pre-separation method (LC,
2D-gel electrophoresis, etc.), ionization and ion detection
method of the mass spectrometer (MALDI-TOF-TOF, etc.),
peak-processing software (ProteoWizard,65; MaxQuant,66; etc.),
protein database used for theoretical peptide mass calculation
(UniProt,44; Ensembl,67; etc.), database search software for peptide-spectral matches (Mascot,68; X!Tandem,69; MaxQuant,66;
etc.), and parameters and thresholds of the software. These
experimental protocol- and data analysis method-related terms
are necessary metadata for submissions to proteome
databases/repositories.
To describe these metadata, the Human Proteome Organization Proteomics Standards Initiative (HUPO-PSI) has developed
the PSI-MS controlled vocabulary70 and ProteomeXchange71,
which is a consortium of mass spectrometry proteomics
data repositories including PRIDE, the Peptide Atlas SRM
Experiment Library (PASSEL,72), and MassIVE73, has established
a core set of metadata for dataset deposition using PSI-MS.
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The Japanese proteome community is now developing the
Japan Proteome Standard (jPOST) repository74, which is a
mass spectrometry proteomics data repository. The salient feature of jPOST is the ability to re-analyze data from deposited
raw data; by using raw data and a jPOST-original re-analysis
workflow, the community plans to integrate data from various
experiments to construct a standardized proteome database
(jPOST database). Original analytical results from submitters
are not suitable for integration because they were performed
using various different protein databases and peak-identification/
database search software with various different parameters.
For re-analysis, it is necessary to describe detailed information about experimental procedures. However, current controlled
vocabularies (CVs) such as PSI-MS are insufficient for metadata
description, and so we have attempted to reorganize and extend
the current CVs for jPOST. At BH15, we enumerated required
categories of metadata, such as Instrument mode and Quantification platform, and collected vocabularies with the cooperation of experimental proteomics scientists. The collected
vocabularies were mapped to existing CVs where possible, and
we began to develop an ontology for unmapped vocabularies75.

We also developed an RDF schema based on the CVs and ontology (Figure 3) for jPOST datasets. Constructing an ontology
that is compatible with existing CVs such as PSI-MS is important for integrating jPOST data with other proteomics data
stored in the databases of the ProteomeXchange Consortium71.
In addition, by using common ontologies/CVs such as Taxonomy and disease name and a standardized data model like RDF,
the proteomics datasets can also be linked and integrated with
datasets derived from other technologies such as transcriptomics
and epigenomics.

Metabolomics
Tools for metabolite identification and interpretation. Metabolomics is the biochemical analysis of all low-molecularweight metabolites in a biological system, i.e. the metabolome.
Owing to the chemical diversity and complexity of the metabolome, no single analytical platform can detect all metabolites
in a sample simultaneously. Current state-of-the-art approaches
for measuring metabolites and maximizing metabolite coverage require integration of multiple analytical platforms, data
pre-processing methods, effective metabolite annotation, and
data interpretation76,77. Given that the most commonly used

Figure 3. RDF schema for jPOST metadata.
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analytical and data pre-processing methods have been comprehensively reviewed78–80, we will not discuss them here, but
rather focus on downstream analyses such as pathway analysis,
and effective data interpretation.
Scientists in natural products chemistry use the accurate mass
and chemical shifts in Nuclear Magnetic Resonance (NMR)
spectra to elucidate the structure of unknown natural chemical
compounds. In contrast, researchers in metabolomics commonly try to provisionally identify chromatographic peaks by
comparing their retention time (or retention indices), and/or the
mass spectra, with those present in a mass spectral library
database generated from the data of authentic standards81.
The Metabolomics Standards Initiative defined four levels of
reporting metabolite identification and annotation: identified
metabolite (Level 1), putatively annotated metabolites (Level
2), putatively annotated metabolite classes (Level 3), and
unknown compounds (Level 4)82. This indicates that the confidence levels of metabolite identification reported in metabolomics studies can vary largely, because of different extraction
protocols, different instruments and measurement parameters,
different pre-processing methods, and the diversity of annotation expertise83. This hampers the reusability/reanalysis of
published metabolomics datasets, although there are public
repositories for metabolomics data such as MetaboLights84 and
MetabolomeExpress.org85.
Biological interpretation of changes in metabolite levels
is very important and is still challenging, because such
metabolite pools are the resulting output of many biological
processes. To facilitate biological interpretation by existing biological knowledge, e.g. biochemical pathways, pathway-based
analysis like Metabolite Set Enrichment Analysis (MSEA,86) is
available. This approach highly depends on predefined biological
pathways such as KEGG87, Pathway Commons88, BioCyc89, and
WikiPathways90. Molecular interactions can be regarded as
a network by calculating association between molecules in
omics data. Correlation-based approaches are behind for construction of association networks such as gene co-expression
networks in transcriptomics (for example, see 91,92).
There are many software tools for pathway visualization and
integration of different omics data (for example, see 93). Examples include KEGG Mapper94, KEGGViewer95, PathVisio96,
WikiPathways App97, and KEGGScape98. Metscape is a
Cytoscape App for network analysis and visualization of genemetabolite associations99. MetaMapR100 can be used for integrating biochemical reaction with chemical structural and mass
spectral similarity to analyze pathway-independent associations
including unknown metabolites. MetaboAnalyst101 provides a
user-friendly, web-based analytical platform for metabolome
data pre-processing, normalization, statistical analysis, and
metabolite annotation. DeviumWeb102 is also a user-friendly web
application for integrating statistical multivariate analysis
with biochemical domain knowledge using R-Shiny103, a web
application framework for R.
Plant metabolome database development. Unlike compound
and mass spectral databases such as KEGG87 and MassBank104,

metabolite-profile oriented databases still remain relatively undeveloped and under-used in plants81. The data and
metadata for more than 140 mutants of Arabidopsis thaliana,
an important model plant, are archived at the Plant and Microbial Metabolomics Resource (PMR,105). It is a flexible database
that is designed for data sharing in metabolomics and implements data analysis tools106. Information on phenotypic screening
of Arabidopsis chloroplast mutants using assays of amino acids
and fatty acids of more than 10,000 T-DNA insertion mutants
using mass spectrometry are stored in Chloroplast 2010107–109.
We recently developed a new database, the Metabolite profiling database for Knock-Out mutants in Arabidopsis (MeKO,110),
to facilitate improvement of gene annotation. The MeKO
database111 can be used to browse and visualize metabolomic
data, containing images of mutants, data on differences in
metabolite levels, and the results of statistical data analyses.
As mentioned above, the metabolomics community is working
towards the setup of sharing metabolome data, while mining
publicly available information and demonstrating the richness
of integration of multiple metabolome datasets that remain
largely unexplored. At present we are constructing our database,
called AtMetExpress112, to store this information. It is freely
available and contains detailed information about metabolites detected in Arabidopsis. It has a small and simple GUI
tool for performing meta-analyses, allowing easy metabolome
meta-analysis for plant biologists using R-Shiny.
Plants produce a diversity of compounds through secondary metabolic pathways. In these secondary compounds, the
flavonoids and glucosinolates are useful as herbal medicines
to maintain human health. However, a lot of them are still
undescribed in public pathway databases. It is therefore important to construct the infrastructure to integrate such metabolites with their pathways in a cross-database manner. Hence,
compounds IDs need to be linked rationally for this purpose.
To address the above challenge, we focused on the following
things at BH15. We tried to implement several web applications
with R-Shiny to improve visualization tools in our metabolome
database, AtMetExpress. To reconstruct secondary metabolite
pathway maps on WikiPathways we curated metabolite name,
database identifiers of metabolites and reactions (KEGG,
KNApSAcK, PlantCyc, and PubChem) in Arabidopsis metabolome data. We focused on flavonoids, which is a well-studied
secondary metabolite group in Arabidopsis. We developed
the following web applications and tools: a webapp called
the Prime Visualization Tool using the R-Shiny framework;
an integrated “pathview” Bioconductor package with the
Prime Visualization Tool113; an R package for the linkdb RDF
client114 to integrate multiple identifiers of major compound
databases like PubChem CID, KEGG, and KNApSAcK.
In addition, we examined the SummarizedExperiment
container115 in Bioconductor to use assay, and we discussed the
possibility of using the SummarizedExperiment in RDF format. We integrated several Arabidopsis metabolome datasets and
partly finished data curations. These curation efforts continue
after BH15. Even in the model plant Arabidopsis, the main target
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of existing large-scale metabolic models was primary metabolism (for example, see 116–119). Our effort to construct curated
Arabidopsis flavonoid dataset will help to expand metabolic
models of Arabidopsis and lead to a better understanding of the
production of flavonoids.

Biochemical molecules
Chemical database integration. Small molecules are studied across a broad set of research areas. They are important as
a vital component of living systems and are also used in the
formulation of pharmaceutical products. Therefore, access to
information collected about molecules is key to research and
product development. During BH15, we discussed strategies for
cooperation between chemical databases. For instance,
participants discussed the role of InChIKey120 in their own databases as a primary key for chemical structure. Other discussions focused on increasing interoperability in two ways: First
by including additional database cross-references, and second by
harmonizing the RDF representation of chemical data. Chemical databases such as PubChem121, Nikkaji122, GlyTouCan123,
and the Protein Database Japan (PDBj,124) store data in atomic
level formats such as Molfile125, mmCIF126, InChI120, and
InChIKey. Participants agreed to use ontologies such as SIO,
the Chemical Information ontology (CHEMINF,53), and the
Simple Knowledge Organization System (SKOS,127). The RDF
data of Nikkaji, KNApSAcK128 and GlyTouCan were modified to use these ontologies. Increased adoption of the ontologybased RDF representation of small molecules will facilitate
their integration and reduce the cost of reuse of data from each
of the databases.
Chemical transformation annotation. We previously developed
an ontology for annotating biochemical transformations called
Partial Information of chemical transformation (PIERO,129).
PIERO provides vocabulary to describe transformations and
their attributes along with sets of possible reactions. The vocabulary enables the examination of similar enzymatic reactions, which is particularly important for reactions for which no
enzyme has been identified yet. Such reactions are common in
secondary metabolism found only in limited organisms. In
most cases, they are just putative substrate-product relationships and the reaction equations are not characterized
completely. During BH15, we augmented PIERO in a number of
ways, including improved RDF interoperability, data curation
(adding/correcting more terminology), and reviewing the
classification criteria for transformations. One of the most
important developments was in the definition of a classification
based on reaction characteristics, including the gain or loss of
groups, opening or closing the ring structures, intermolecular
transfer of groups, formation/digestion of groups, transfer/exchange
of groups, and the steps of the reactions.
Glycomics ontology development. Carbohydrates, often referred
to as glycans, differ from other biopolymers such as proteins or
nucleic acids in the large variety of different building blocks,
i.e., monosaccharides, and in the possibility of linking these
building blocks in several ways, which often results in branched
structures. Furthermore, experimental techniques for glycan

identification often yield underdetermined structures with
varying degrees of uncertainties. Many providers of glycoinformatics databases and tools have developed individual and
non-compatible formats to store all these properties of glycan
structures, such as LINUCS130, LinearCode®131, KCF132,
GLYDE133, GlycoCT134, or WURCS135. This variety of nomenclature formats is a major reason for a lack of interoperability and data exchange between various glycoinformatics
resources136,137. To overcome this situation, development of the
glycomics standard ontology (GlycoRDF,138,139) was started
during BioHackathon 20124.
GlycoRDF can represent glycan structure information
together with literature references or experimental data.
MonosaccharideDB140
provides
GlycoRDF
descriptions
of monosaccharides generated from various carbohydrate
nomenclature formats. During BH15, participants developed
routines to generate GlycoRDF data from WURCS 2.0 nomenclature, which is used by the GlyTouCan structure repository123.
Thus, glycomics data can now be retrieved as GlycoRDF from
GlyTouCan, GlycoEpitope75, GlycoNAVI141 and WURCS using
database guidelines142.
The group also discussed possible extensions to GlycoRDF
that would offer relations between individual monosaccharides. Lactose, for example, is a disaccharide composed of
β-D-galactopyranose (1-4)-linked to D-glucose. The latter can
be of any ring form or anomeric state due to mutarotation.
With relations such as “β-D-glucopyranose is_a D-glucose”
or “α-D-glucofuranose is_a D-glucose”, the definition of
lactose given above can be used to identify disaccharides with
β-D-galactopyranose (1-4)-linked to β-D-glucopyranose or to
α-D-glucofuranose as lactose as well. Options to derive such
relations from WURCS 2.0 nomenclature have also been discussed. The encoding of these relations in RDF uses existing
chemistry definitions such as SIO as much as possible. A first
implementation of creating such relations automatically has
been added to MonosaccharideDB. The resulting representation
will enable (sub-)structure searches with different levels of
information in query and target structures, and will also help
to assign relations between oligosaccharides.
Glycoinformatics is at the intersection of bioinformatics
and chemoinformatics. In the past there have mainly been
attempts to establish cross-links between glycan databases and
bioinformatics resources, e.g. between UniCarbKB143 and
UniProtKB44, which makes sense from the point of view of
glycoproteins and protein-carbohydrate complexes. From the
small molecules perspective it is coherent to also cross-link
with chemoinformatics databases such as PubChem121 or Nikkaji
(now subsumed by J-Global,122). Glycan structures cooperation was discussed at BH15. As part of this process several
possible formats for data exchange were discussed, such as
SMILES144, InChI, mmCIF, WURCS, or mol file. A focus was
subsequently put on the conversion of glycan structures to
SMILES, and routines to generate SMILES codes from monosaccharide names were developed in a cooperation between
PubChem and MonosaccharideDB developers. This will
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provide an important bridge between glycoinformatics and
chemoinformatics and will make it easier for people outside the
glycoscience community to access glycomics data. For cooperation between GlyTouCan and PubChem, RDF triples were
developed with GlycoRDF, SIO, CHEMINF, DCT, and
SKOS.
The large variety of monosaccharides is mainly caused by the
fact that the basic building blocks such as glucose or galactose are often modified by substituents that replace hydrogen
atoms or hydroxyl groups, or by introduction of double bonds,
deoxy modifications, etc. Currently, no explicit rules exist to
define how many modifications can be made to a standard monosaccharide so that it can still be considered as a
monosaccharide. Some possible criteria for discrimination
between carbohydrate and non-carbohydrate residues were
discussed at BH15. We developed a new approach for detecting carbohydrate candidate backbone skeleton. An algorithm for
automatic detection of candidate carbon chains of monosaccharide
was discussed.

Research methods
Data retrieval and querying
OpenLifeData to SADI deployment. The Bio2RDF project145
is now well known within the life sciences LOD community.
Recently, OpenLifeData146 completed an effort to provide a distinct view over the Bio2RDF data, with deeper and more rigorous attention to the semantics of the graph, and these views were
provided through a distinct set of SPARQL endpoints, with each
endpoint acting as a query-rewriter over the original Bio2RDF
data147. With these richer and more uniform semantics, it
became possible to index each endpoint and automate the
construction of SADI Semantic Web Services148 providing discoverable, service-oriented access to all OpenLifeData/Bio2RDF
data149—a project that was named OpenLifeData2SADI.
Prior to BH15, the OpenLifeData endpoints were further consolidated into a single endpoint, which caused the
OpenLifeData2SADI services to fail. At BH15, the SADI and
OpenLifeData project leaders took the opportunity to rewrite
the OpenLifeData2SADI automated service deployment codebase. This was originally written as an interdependent mix of
Java and Perl scripts, which often took several days to complete. The new codebase is entirely Perl-based, and with the
exception of the OpenLifeData indexing step, which is highly
dependent on the size of the available OpenLifeData endpoints, runs in less than one hour, deploying tens of thousands
of SADI Semantic Web Services over the refactored data. The
speed of this new code makes it reasonable to rerun the service deployment dynamically as the underlying OpenLifeData
expands or changes, or perhaps automate the re-deployment
of services on, for example, a nightly basis. In an ongoing activity since BH15, re-indexing of OpenLifeData has made it
possible to capture sample inputs and outputs for each of the
resulting SADI services. This information will be added to the
SADI service definition documents, allowing for automated
service testing and/or more intuitive service registry browser
design with, for example, pre-populated “try it now” functionality.

SPARQL query construction. SPARQL150 has emerged as
the most widely used query language for RDF datasets. RDF
datasets are often provided with web interfaces, called SPARQL
endpoints, through which SPARQL queries can be submitted.
However, constructing a SPARQL query is a relatively complex
task for inexperienced users. SPARQL Builder151 is a web application that assists users in writing SPARQL queries through a
graphical user interface. The SPARQL Builder system interactively generates a SPARQL query based on a user-specified
path across class-class relationships. At BH15, we worked on the
display of candidate paths from metadata, including hierarchical
information of the SPARQL endpoint, graphs, classes, properties,
class-class relationships, and their statistics, such as the numbers of triples and instances. To be time efficient, we found
that it was necessary to pre-compute and store those metadata
for fast retrieval. This suggests that it would be ideal that every
SPARQL endpoint provides such metadata. We tested our system
on datasets drawn from the EBI RDF Platform and Bio2RDF,
and our approach could be extended to other RDF datasets.
We also developed a prototype152 of a search interface using
SPARQL Builder system for 439 datasets contained in the
Life Science Database Archive (LSDB Archive,153). The LSDB
Archive is a service to collect, preserve and provide databases generated by life sciences researchers in Japan. Using the
interface, we can now search for data in the LSDB Archive
without knowing the data schema for each dataset.
LODQA integration with DisGeNET and Bio2RDF. LODQA154
is another service being developed to provide a natural
language interface to SPARQL endpoints. Users can begin
their search with a natural language query, e.g. What genes are
associated with Alzheimer’s disease?, from which the system
automatically generates corresponding SPARQL queries.
LODQA also features a graph editor that allows users to
compose queries in a graph representation. While the system is developed to be highly adaptable to any RDF datasets,
it does require lexical terms, e.g. labels, of data sets to be
pre-indexed.
During BH15, we explored the use of the LODQA system with
DisGeNET and Bio2RDF. As a result, we found that LODQA
could generate effective SPARQL queries for some natural language questions like “Which genes are involved in calcium binding?” The LODQA interface to Bio2RDF is publicly
available155, while the LODQA interface to DisGeNET is
discontinued due to major revisions to DisGeNET.
Crick-Chan query parsing. While LOD and the Semantic
Web are rapidly adopted in the biology domain, the majority of biological knowledge is still only available in the form of
natural language text, for example in manuscripts on PubMed
or in textbooks on the NCBI Bookshelf. The ability to make
use of this ocean of data would facilitate knowledge discovery
and help bridge the current data retrieval process and the Semantic Web. The success of IBM Watson in the quiz show Jeopardy highlighted the potential of state-of-the-art cognitive
computing in answering natural language questions. IBM
Watson, however, does not rely so much on semantics or
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machine learning, but is rather based on queries on unstructured data, with statistical identification of answer domains
(Lexical Answer Type). The software for IBM Watson
(DeepQA) uses a system to answer a “word” that matches the
natural language query by searching through millions of pages
of documents, including the entire text of Wikipedia. A
scientific fact, or indeed any knowledge, is almost always
written in natural language in the form of a manuscript, use of
which is relatively less explored in the Semantic Web context. Therefore, at BH15 the G-language Project team aimed
to develop a software system, designated “Crick-chan”, that mimics DeepQA to find the most relevant “sentence” (as opposed
to a “word” in Watson) from millions of scientific documents.
Crick-chan mimics the architecture, and works as follows:
1. T
 he question text first undergoes morphological analysis using Enju156 to extract objective nouns and key
verbs. Using a dictionary search, proper nouns are
identified.
2. Q
 ueries are extended using the Bing search engine
(which allows for the largest number of free queries
among search engines). At the same time, the question is
checked to see whether it belongs to the biology domain.
3. F
 ull text searches are performed for the entire OMIM,
PubMed, PubMedCentral, NCBI Bookshelf, Wikipedia,
and the entire WWW, via queries to NCBI EUtils and
Bing searches.

4. R
 elevant sentences are extracted from the most relevant
matches.
5. E
 xtracted sentences, i.e. the answer hypothesis, are
checked for grammatical completeness and are scored
according to keywords.
6. A
 nswer confidence is scored according to the data
sources and the completeness of key terms.
7. T
 he resulting “answer” is presented in a user interface
with an artificial character to assist the natural language
query process.
For other general conversation, Crick-chan embeds the AIML
bot (ProgramV 0.09) for cases when the question is not considered to belong to the biology domain, and for when there are
fewer than two keywords. Crick-chan is publicly accessible157
and it can answer natural language questions such as
“What genes are associated with Alzheimer disease?” (Figure 4).

Natural language processing
Clinical phenotype text mining. Clinical phenotypes, i.e.
symptoms and signs, are key for diagnosis and treatment
decision-making, particularly for rare or complex disorders158.
Delayed or inaccurate diagnosis incurs high economic costs
in addition to heavy psychological burden on patients and
their families. Deep clinical phenotyping in combination with
genotyping are increasingly seen as important components of

Figure 4. The graphical interface of Crick-chan as it answers which genes are associated with Alzheimer’s disease.
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a vision for precision medicine159. However, vast amounts of
phenotypic data available from social media, EHR, biomedical
databases, and the scientific literature, are largely inaccessible
to direct computation because they are solely available in a
narrative form.
Natural Language Processing (NLP) involves the automatic
extraction of relevant information from unstructured text
and represents it in the form of structured concepts and relationships amenable to further computational analysis. The
acquisition of phenotype data is particularly challenging
due to the complexity of textual descriptions. Several efforts
have explored the extraction of phenotypes from text. For
example160, assessed the contribution of feature spaces and
training data size on support vector machine model performance for mining phenotypic information on obesity, atherosclerotic cardiovascular disease, hyperlipidemia, hypertension, and
diabetes from clinical documents. In the domain of congestive heart failure161, developed automated methods for extracting
phenotypic information from clinical documents and from published literature. With the goal of matching phenotypic findings to their correlated anatomical locations as described in
clinical discharge summaries162, developed a named entity recognition method based on the Epilepsy and Seizure Ontology
(EpSO,163). In fact, a review of studies describing systems
or reporting techniques developed for identifying cohorts
of patients with specific phenotypes found that 46 out of 97
papers on this topic used techniques based on natural language
processing164. In addition, several phenotype-annotated datasets have been recently extracted from journal articles and
EHR by using BioNLP and text mining methodologies158,165–169.
The large-scale acquisition of phenotypic relationships from the
literature enable a more complete view on the current knowledge, and thus, more efficient science. The use of text-mined
data, i.e. information that is programmatically processed,
aggregated and mined, shows much promise for some
current challenges such as phenotype definition, hypothesis
generation for research, understanding disease and pharmacovigilance. Therefore, their representation as linked data using
Semantic Web and LOD approaches and the linking of the
annotated literature with the linked data open new avenues for
knowledge discovery to advance research and improve health
care.
The curation of biomedical information extracted from scientific
publications by text mining is an important current bottleneck
for knowledge discovery of new and original solutions for a
better health and quality of life. Manual approaches for data
curation become more and more time demanding and costly, so
that computer assistance in screening (document retrieval) and
preparing data (information extraction) is unavoidable. Crowdsourcing approaches have been recently applied with high
accuracy170. Therefore, biocuration over the LOD will give a
new opportunity to validate knowledge and adding evidence at
the same time. The integration of curated and text mined data
in the LOD opens new challenges for evidence and provenance
tracking. Recent use of the nanopublication approach gives

a mechanism
tracking171,172.

for

evidence,

provenance

and

attribution

BH15 offered an opportunity to address different challenges
related to the capture and analysis of human phenotype data.
The text mining group focused its effort in the primary domains
for deep phenotyping: acquisition of phenotype associations
from journal articles, integration and alignment of annotation
BioNLP tools, evaluation of secondary use of text mining corpora for knowledge discovery, semantic integration of text mined
and curated data in the LOD, and curation of text mined
data. All these tasks were pursued with a clear emphasis on
standardization and interoperability between life sciences
databases, text mined datasets and BioNLP tools, with the further
aim to linking to the LOD.
Natural language processing of drug effects and indications.
Structured drug labels have been used as a source to collect
rich representations of drug effects and indications173–175,
and these text mined representations have been used in drug
repurposing and identification of new targets for known
drugs. The Side Effect Resource (SIDER,176) contains a collection of text mined drug effects and indications, using the
Unified Medical Language System (UMLS,177) to represent the
phenotypes. While the UMLS covers a wide range of
clinical signs and symptoms, it does not cover the full set of
phenotypes described in non-UMLS biomedical ontologies
such as the human Disease Ontology (DO,178) and the Mammalian
Phenotype ontology (MP,179).
During BH15, we developed an NLP pipeline that identifies
the phenotypes occurring in structured drug labels. As vocabularies, we use the phenotype ontologies for mammals, in
particular the the Human Phenotype Ontology (HPO,26,166), MP,
and the DO. Furthermore, we also use the phenotypic quality
ontology (PATO,180), and the Foundational Model of Anatomy
(FMA,181), an ontology of human anatomy, as additional
vocabularies. Text processing is performed using Lucene,
which includes basic text normalization such as stop-word
removal and normalization to singular forms. The resulting
text-mined annotations of the structured drug labels are freely
available182. In the future, these annotations of drugs need to be
further evaluated and integrated in linked datasets.
Data analysis of text-mined corpora. The combination of highthroughput sequencing and deep clinical phenotyping offers
improved capability in pinpointing the underlying genetic
etiology of rare disorders. The accuracy of hybrid diagnosis
systems is challenged by the vast number of associated variants, many of which lack phenotypic descriptions. At BH15,
we sought to learn possible genotype-phenotype relationships
from text mining. Specifically, we aimed to use text-mined
corpora to learn associations between biological processes
disrupted by gene mutations with externalized phenotypes. To
do so, we combined two PubMed datasets: i) a dataset generated by the Biomedical Text Mining Group (BTMG) at NIH,
comprised of automatically extracted named entities (MeSH
terms, genes and mutations); and ii) a second one, generated
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by the Phenomics team at the Kinghorn Centre for Clinical
Genomics (KCCG). The latter covered structured PubMed metadata, i.e., MeSH terms, keywords, etc., as well as HPO annotations. The consolidation of the two datasets, via common MeSH
terms, resulted in a final corpus of 6.5M abstracts. To learn
biological process – phenotype associations, we added biological process annotations from the Gene Ontology (GO,183). Using
the underlying diseases as latent variables (via MeSH terms)
and summation as aggregation function, we produced an association matrix between 7,666 HPO terms and 10,438 GO
Biological Process terms. The actual use of the matrix has
been left for future experiments. Such experiments may cover
various aggregation functions (e.g., instead of summation, to use
a linear interpolation of the term frequency inverse document
frequency (TF-IDF) values of the HPO terms) as well as its
application to discovering dense networks of phenotypes –
biological processes. The latter could be achieved via some of the
following mechanisms:
• H
 ierarchical clustering and singular value decomposition
(SVD) for ranking HPO - GO BP associations.
• P
 re-clustering of HPO terms based on the HPO
top-level abnormalities.
• P
 re-clustering of GO BP terms using higher-level
common ancestors.
Integration of text-mined and curated disease-phenotype
data. DisGeNET-RDF contributes to LOD with Gene-Disease
Associations (GDAs) obtained from Medline by text mining
and integration with associations from different authoritative
sources in human genetics184. From release 3.0.0, DisGeNETRDF also integrates curated Disease-Phenotype Associations
(DPAs) to HPO terms for diseases in OMIM, Orphanet, and
DECIPHER185 from the HPO project26. In order to examine what
are the challenges to integrate text mining with curated DPAs
in LOD, we analyzed the DPAs in DisGeNET-RDF (v3.0.0)
and the DPAs text-mined from the scientific literature by
Hoehndorf et al.167.
• H
 oehndorf2015: This text-mining DPAs dataset contains
6,220 diseases identified by DO identifiers (DOIDs),
9,646 phenotypes identified using the HPO and the
MP, and 124,213 DPAs.
• H
 PO2015: This curated DPAs dataset contains 113,203
DPAs between 7,841 diseases and 6,838 phenotypes
from OMIM, Orphanet and DECIPHER data sources
in which diseases are identified by the corresponding
database identifier of provenance, and phenotypes are
uniformly identified by HPO identifiers.
We normalized 6,220 diseases from the Hoehndorf2015 dataset to 5,194 UMLS CUIs by DOID-UMLS cross-references
extracted from DO version 2015-06-04 with which only 75%
(4,648) of DOIDs can be mapped to UMLS concepts. This is
because 17% (1,088) of diseases are described with obsolete
DOIDs and 8% (484 DOIDs) do not map to UMLS. Additionally, not all are 1:1 mappings, some N:1 DOID-CUI mappings

exist. Therefore, phenotype annotations for different diseases will
collapse in a unique UMLS concept.
The integration of the HPO2015 and Hoehndorf2015 datasets (9,067 and 5,194 UMLS CUIs, respectively) covers 13,596
UMLS concepts of the disease spectrum, of which only 3.2%
(665 UMLS CUIs) are in both datasets. This low overlap is due
to the fact that each project mainly focuses on covering different disease areas. Whilst the HPO annotation is intended to
annotate Mendelian and rare genetic diseases, Hoehndorf et al.’s
large-scale literature extraction was focused on broadening the
disease class landscape to infectious, environmental, and common diseases. To characterize the disease coverage yielded
only by text mining; in Figure 5 we show the top-level DO
categories where these novel diseases fall. As can be seen, these
novel findings mostly fall in ‘Disease of anatomical entity’
(DOID:7) and ‘disease of cellular proliferation’ (DOID:14566).
In summary, the analysis of aggregation and integration of
text mined and curated disease-phenotype associations in DisGeNET highlights the potential value of text mining in data
completeness, annotation, integration, and network biology,
which can be used for instance for disease-phenotype ontology construction and curation, knowledge base population, and
document annotation. The large-scale integration and publication
of text mining DPAs in DisGeNET-RDF opens inference
opportunities to grasp potential novel gene-phenotype associations from the current knowledge that promotes our understanding about disease etiology and drug action. However, it
is important to keep track of machine-readable provenance and
evidence at relationship level for computational analysis and
credible knowledge discovery using LOD. Finally, the increase
of disease/phenotype terminology and ontology mapping
is crucial to foster semantic interoperability and data coverage.
Assessing interoperability of disease terminologies. One benefit of improving the interoperability of disease terminologies
is to facilitate translational research and biomedical discovery. Phenotype information is represented using terminologies,
vocabularies, and ontologies, but the diverse phenotype spectrum poses serious challenges for their interoperability. For one,
phenotypes span from the molecular to the organismal. In addition, while phenotypes in the biological domain are recorded
as results from biological experiments, phenotypes in the clinical domain are used to report the state condition of patients186.
Furthermore, in current clinical nomenclatures for phenotypes
such as MeSH, the 10th revision of the International Statistical Classification of Diseases and Related Health Problems
(ICD-10), the nomenclature of the National Cancer Institute
(NCI), SNOMED Clinical Terms (SNOMED CT), and UMLS,
concepts are covered inconsistently and incompletely186. All these
issues affect ontology interoperability, and thus, the quality of
their applications. The systematic ontological coding of phenotypic and molecular information in databases and their linking
facilitates computational integrative approaches for identifying novel disease-related molecular information187, prioritizing
candidate genes for diseases188–191, as well as predicting novel
drug-target interactions, drug targets, and indications192,193. The
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Figure 5. Disease coverage for top-level categories in DO of the diseases only annotated in the Hoehndorf2015 DPA dataset in
comparison to the HPO2015 annotation.

quality of the phenotypic descriptions of a resource will have
implications for the quality of their interoperability, and thus,
the quality of computational data analyses performed for
translational research and knowledge discovery.
In DisGeNET-RDF (v3.0.0), diseases are normalized with the
UMLS CUIs, and are mapped to several disease vocabularies/ontologies with different coverage (see 194 to see disease
mapping coverage statistics). Much of the disease data in the
data sources of the European Bioinformatics Institute (EBI) is
annotated with EFO, such as BioSamples, which aggregates
sample information for reference samples and samples used in
multi-omics experiments, and the Gene Expression Atlas, which
collects gene expression experiments. EFO disease terms have
mappings to UMLS, DOID, MeSH, SNOMED CT, OMIM,
HPO and ICD-10. EFO also includes and reuses terms from
external terminologies such as disease/phenotype terms from
the DO, the HPO, and rare disease terms from the Orphanet
Rare Disease Ontology (ORDO,195) that include some additional
mapping to OMIM and UMLS. In this regard, during BH15,
we aimed to increase the integration of DisGeNET and EBI
data, by way of its RDF platform.
We assessed the coverage of EFO concepts against UMLS; from
a total of 5,260 terms, only 52 map to the UMLS (see Table 3).
Some disease terms do not have cross-references to UMLS
concepts. For instance, cancer (EFO_0000311) does not have
UMLS CUIs associated, even though it is a general disease term.
Nevertheless, the EFO contains over 2000 UMLS mappings

from other ontologies, most of them from ORDO, which are
manually curated. We suggest that an increase in the mapping
between EFO and the UMLS terminologies will benefit data
integration and interoperability between RDF datasets such
as DisGeNET and other databases that are part of EBI RDF
platform.
Semantic haiku generation. Natural language generation is the
longstanding problem of generating textual output from textual
or non-textual sources196–200. The field has a number of potential applications in the life sciences201–205. One of the projects
of BH15 included the construction of a “semantic” haiku
generator. Realizing the potential of language generation in
communicating information both to scientists and to the public in a way that is acceptable to readers requires the ability to
generate text that meets user expectations regarding discourse
cohesiveness, genre-appropriate characteristics of word structure, e.g. length, and the like. Poetry generation has been an
active area of research in computational linguistics and natural
language processing for some time. Here we extend the task
definition to the use of LOD, and to the haiku structure,
which has not previously been treated in the language generation literature42,206–210. A haiku is a type of poem traditional to
Japan; it consists of three verses with five, seven, and five
syllables. In light of the work on semantic resources, in particular RDF datasets available through SPARQL, the idea arose
to generate a haiku from a SPARQL query by identifying a
connected subgraph in which the labels of the resources, or the
properties linking them, follow the 5-7-5 syllable pattern of a
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haiku. Using the CELEX2 dictionary211, which maps English
words to their syllables, we wrote a small haiku generator that
can be initialized with a SPARQL endpoint and a start node (a
resource) from which a search is started to identify a subgraph
with the haiku pattern. The prototype code is available at our
source code repository62,212. An initial test of the script using the
UniProt SPARQL endpoint together with the human Amyloid
beta213 protein, which resulted in the following haiku:
Amyloid beta
protein classified with blood
Coagulation
To the best of our knowledge, this is the first “semantic” haiku.
Although it follows the haiku pattern, additional work is still
required to generate haikus that have additional haiku qualities,
in particular the occurrence of a word related to one of the four
seasons, as tradition requires.

Reproducibility
Extending the Common Workflow Language. Computational
genomics faces challenges of scalability, reproducibility, and
provenance tracking. Larger datasets, such as those produced
by The Cancer Genome Atlas214, are now petabyte-sized, while
procedures for read mapping, variant calling, genome assembly, and downstream imputation have grown impressively
sophisticated, involving numerous steps by various programs.
In addition to the need for reproducible, reusable, and trustworthy data, there is also the question of capturing reproducible
data analysis, i.e. the steps that happen after raw data retrieval.
Genomics analyses involving DNA or RNA sequencing are
being used not just for primary research, but now also within
the clinic, adding a legal component that makes it essential that
analyses can be precisely reproduced. We formed a working
group on the challenges of creating pipelines for reproducible
data analysis in the context of semantic technologies.
With the advent of large sequencing efforts, pipelines are
getting wider attention in bioinformatics now that biologists
regularly have to deal with terabytes of data215. This data can
no longer be easily analyzed on single workstations, requiring
that analysis is executed on computer clusters and analysis steps
are run both serially and in parallel on multiple machines, using
numerous software programs. To describe such a complex
setup, pipeline runners, or engines, are being developed.
One key insight from this development is that versioned software is a form of data and can be represented with a unique hash
value, e.g., a Secure Hash Algorithm (SHA) value can be calculated over the source code or the binary executables. Also,
the steps in a pipeline can be captured in scripts or data and can
be represented by a unique hash value, such as calculated by
git. This means that the full data analysis can be captured in
a single hash value that uniquely identifies a result with the
used software and executed analysis steps, together with the
raw data.
We worked on the Common Workflow Language (CWL,216),
which abstracts away the underlying platform and describes

the workflow in a language that can be used on different computing platforms. To describe the deployed software and make
reproducible software installation a reality we also worked on
virtualization (Docker) and software packaging and discovery
(GNU Guix).
The CWL is an initiative to describe command line tools and
connect them together to create workflows. The original idea
of CWL is that a workflow can be described in a ‘document’
and this workflow, once described, can be rerun in different
environments. CWL has roots in “make” and similar tools that
determine order of execution based on dependency graphs of
tasks. Unlike “make”, CWL tasks are isolated and the user
must be explicit about its inputs and outputs thereby creating a (hopefully reproducible) document of the workflow.
The benefits of explicitness and isolation are flexibility, portability, and scalability: tools and workflows described with CWL
can transparently leverage software deployment technologies, such as Docker, be used with CWL implementations
from different vendors, and are well suited for describing
large-scale workflows in cluster, cloud, and high-performance
computing environments where tasks are scheduled in parallel
across many nodes.
At BH15, CWL support was added for the Toil workflow engine217
and work was done on Schema Salad, which is the module
used to process YAML CWL files into JSON-LD linked data
documents. A tutorial was given on the Common Workflow
Language to interested participants. CWL also added the
ability to pipe-in JSON objects containing the parameters
necessary to run a CWL-wrapped tool218. This allowed CWL
to be more easily used with Node.js Streams and thus with the
Bionode.io project.
Docker container registry development. One challenge is the
creation of standard mechanisms for running tools reproducibly and efficiently. Container solutions, such as Docker, have
gained popularity as a solution to this problem. Container technologies have less overhead than full virtual machines (VMs)
and are smaller in size. At BH15, we started a registry of
bioinformatics Docker containers, which can be used from the
CWL, for example. From this meeting evolved the GA4GH
Tool Registry API219 that provides ontology-based metadata describing inputs and outputs. Work was also done on
an Ensembl API in Docker220.
To facilitate access to triple stores, we developed a package called Bio-Virtuoso based on Docker. The virtuoso-goloso
container runs an instance of the Virtuoso triple store221. This
container also receives Turtle, RDF/XML, and OWL format files via the HTTP Post method and internally put them
into Virtuoso speedy using the isql command. Graph-feeding
containers download data from sources, convert them into RDF
if necessary, and send them to virtuoso-goloso. Multiple graphfeeding containers can be combined on demand. To date, we
have supported data sources such as the HPO, HPO-annotation,
Online Mendelian Inheritance in Man (OMIM,222), OrphaNet223,
the HUGO Gene Nomenclature Committee (HGNC,224), OMIM
Japanese translation by Gendoo225, and MP179. Bio-Virtuoso
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is expected to lower barriers to learn SPARQL using real dataset
and develop SPARQL-based applications. The project has a
GitHub repository226.
GNU Guix extension and deployment. One problem of
Docker-based deployment is that it requires special permissions from the Linux kernel, which are not given in many HPC
environments. More importantly, Docker binary images are
‘opaque’, i.e., it is not clear what is inside the container—and
its state is affected by what time the container was created and
what software is installed, i.e., an intermediate apt-update may
generate a different image. Distributing binary images can be
considered a security risk—users have to trust the party who
created the image227. An alternative to using Docker is using
the GNU Guix packaging and deployment system228, which
takes a more rigorous approach towards reproducible software
deployment. Guix packages, including dependencies, are built
from source and generate byte-identical outputs. The hash value
of a Guix package is calculated over the source code, the build
configuration (inputs), and the dependencies. This means that
Guix produces a fully tractable deployment graph that can be
regenerated at any time. Guix also supports binary installs
and does not require special kernel privileges. As of October
2016, Guix has fast growing support for Perl (473 packages),
Python (778), Ruby (153), and R (277). Guix already includes
182 bioinformatics and 136 statistics packages.
At BH15, we added more bioinformatics packages and
documentation229 to GNU Guix and created a deployment of
Guix inside a Docker container230. We also packaged CWL in
Guix and added support for Ruby gems to Guix which means
that existing Ruby packages can easily be deployed in Guix,
similar to support for Python packages and R packages. Guix
comes with a continuous integration system on a build farm.
We want to harvest that information to see when packages are
building or failing. See, for example, the Ruby builds231, which
contain the SHA values of the package as well as the checkout of the Guix git repository reflecting the exact dependency
graph. We are collaborating with Nix and Guix communities
to get this information as JSON output so it can be used in a web
service.

Semantic metadata
Assessing the Findable, Accessible, Interoperable, and Reusable
Principles. Loosely defined practices in scholarly data publishing prevent researchers from extracting maximum benefit
from data intensive research activities, and in some cases make
them entirely unusable232. There has been a growing movement
encompassing funding agencies, publishers, academics, and the
public at large to promote “good data management/stewardship”,
and to define and enforce more stringent rules around the
publication of digital research objects, including published
data, associated software, and workflows, so that they are easily discoverable and readily available for reuse in downstream
investigations233. These include international initiatives such as
the Research Data Alliance (RDA,234 and235), and Force11236.
However, the precise nature and practice of “good data

management/stewardship” has largely been up to the producer
of digital objects. Therefore, bringing some clarity around the
goals and desiderata of good data management and stewardship, and defining simple guideposts to inform those who
publish and/or preserve scholarly data, would be of great utility.
Stakeholders in the publication of research data, including several authors of this article, participated in the development
of an initial draft of the Findable, Accessible, Interoperable,
and Reusable (FAIR) principles. The principles were intended
to define the key desiderata for the features and/or behaviors
that should exist to facilitate data discovery and appropriate
scholarly reuse and citation. A public draft237 was published
for public comment, and BH15 participants formed a breakout group to carefully examine them against the following criteria: necessity, clarity, conciseness, independence, sufficiency,
implementability and relevance. Our critical evaluation led to the
development of a revised set of principles that were actionable,
and improved coverage and comprehension. The text of these
principles was published verbatim in a recent issue of Scientific Data238. These revised principles have been widely lauded239
by researchers240,241, and US and European agencies such as
the National Institutes of Health (NIH,242,243) and Elixir244, as
being highly informative and providing insight into what it
means to be “FAIR”. Future work will focus on the development of quantitative measures of adherence to the principles to
assess the FAIRness of a digital resource.
FAIR projector prototype development. Data discovery, integration, and reuse are a pervasive challenge for life sciences
research. This is becoming even more acute with the rise of
scholarly self-archiving. Much effort has been devoted to
the problem of data interoperability, whether through data
warehousing245, ontology-based query answering246, or shared
application programming interfaces (APIs,247). At BH15, a
group of participants further developed a novel idea that was
first proposed at a Data FAIRport meeting in 2014, called FAIR
Projectors. FAIR Projectors are simple software applications
that implement the FAIR principles by “projecting” data in any
format (FAIR or non-FAIR) into a FAIR format. A projector will
make use of a template-like document called a FAIR Profile,
which acts as a meta-schema for the underlying data source.
These meta-schemas may be indexed as a means to discover the
projection of a dataset that matches the integrative requirements,
i.e. the structure and semantics, of a particular workflow.
To be FAIR themselves, and thus reusable, we have selected
the RDF Modeling Language (RML,248), where RDF documents are used to model the structure and semantics of another
RDF document. For the functionality of the Projectors, we
identified an emergent, RESTful, LOD technology – Triple
Pattern Fragments (TPF,1), as a compelling platform that could
execute the desired Projector behavior without inventing a new
API. This is because TPF natively uses RDF model to publish information which can be served as a RESTful API and
thus realizes a Linked Data service by nature. By the end of
BH15, we had completed a prototype FAIR Projection system,
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and had shown how this could be integrated with other components of the nascent FAIR Data publication infrastructure. The
result of this development exercise was recently published249.

Table 1. Exhaustive metadata for mappings.
Attribute

Source

Ontology metadata mapping. Identification of equivalent or
similar concepts between vocabularies is key to the analysis of
aggregated datasets that use different terminologies. Efforts such
as UMLS build and maintain a system for mapping biomedical ontologies to one another. However, such mappings depend
on specific versions of the ontologies, and any one version can
impact scientific analyses250. Therefore, having access to ontology and mapping metadata is critical to the interpretation and
reproducibility of results for bioinformatics research. Initiatives
such as the Open Biomedical Ontologies (OBO) Foundry251,
Linked Open Vocabularies (LOV,252) and the National Center
for Biomedical Ontology’s (NCBO) BioPortal253 have
put forward schemas for ontology metadata. The Ontology
Metadata Vocabulary (OMV,254) was first published in 2005,
but does not reuse current standard vocabularies. In contrast,
the Metadata for Ontology Description (MOD,255) does reuse
existing properties from SKOS, Friend Of A Friend (FOAF,256)
and Dublin Core and Dublin Core Terms (DC, DCT,257).

Identifier (IRI)

FAIR

Title

Open PHACTS

Description

Open PHACTS

Publisher

Open PHACTS

License

Open PHACTS

Issued

Open PHACTS

Link to mapping file

Open PHACTS

Type of Subject

Open PHACTS

Type of Object

Open PHACTS

Type of Mapping

Open PHACTS

Link to Subject dataset metadata

Open PHACTS

Link to Object dataset metadata

Open PHACTS

Mapping relationship

Open PHACTS

Mapping justification

Open PHACTS

Recently, the W3C Semantic Web for Health Care and Life Sciences Interest Group258 published a computable specification for
the description of datasets, which could also be applied to the
description of ontologies259. With respect to mappings and their
metadata, SKOS offers a lightweight system for terminology
mappings, while Open Pharmacological Concept Triple Store
(Open PHACTS,260) put forward a more detailed proposal261
for mappings between RDF datasets, or LinkSets. Yet, in our
experience, additional attributes are needed for both ontology and mapping metadata. Therefore, we propose an enhanced
metadata scheme as a best practice for ontologies and mappings so as to improve their discovery, analyses, and reporting
of results.

Authorship-who

Open PHACTS

Authorship-when

Open PHACTS

Creator-who

Open PHACTS

Creator-when

Open PHACTS

Version of mapping tool

Open PHACTS

Assertion method

Open PHACTS

Assertion value (exact, ntbt, …)

ORDO

Mapping directionality

OBAN

Mapping state (active, obsolete, other)

BioHackathon 2015

Concept overlap value (n:m)

BioHackathon 2015

Our goal was to define a minimal set of attributes and standards for ontology mapping metadata. We used manually defined
and automatically detected disease mappings in DisGeNET262
as a case study263. Our approach involved compiling attributes
from the use case, identifying metadata requirements from
related initiatives including ontology repositories (Ontobee,264;
the Ontology Lookup Service, OLS36; NCBO BioPortal;
Aber-OWL,265), large-scale providers of mappings (UMLS,
NCBO, Open PHACTS), as well as from individual ontologies
including the DO178, HPO26,166, ORDO195, SIO266, the Ontology
for Biomedical Investigations (OBI,267) and the Experimental Factor Ontology (EFO,268). We analyzed the mapping
metadata and devised a more exhaustive metadata specification
for mappings (Table 1) and ontologies (Table 2).

Provenance/source of mapping
(ontology/dictionary/database +
version)

BioHackathon 2015

Evidence (PMID, Web, EHR..)

BioHackathon 2015

Curation state

ORDO

Curation author

ORDO

Curation date

ORDO

Curation justification

BioHackathon 2015

Mapping version

BioHackathon 2015

Mapping previous version

BioHackathon 2015

Link to the linkset metadata

BioHackathon 2015

Ontology version

BioHackathon 2015

Link to the ontology metadata

BioHackathon 2015

Link to mapping tool metadata

BioHackathon 2015

Sustainability (code development
environment)

BioHackathon 2015

Our work revealed a lack of common annotation in the description of mappings in both the attributes and vocabularies used.
The inclusion of justification, provenance, evidence, directionality and versioning of mapping metadata has the potential to
increase trust in the interpretation, reliability and reusability of
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and Aber-OWL, ontology and data mapping services, and
for methods geared towards scientific discovery. The right
vocabulary for the metadata description of mappings should be
determined through wide community agreement.

Table 2. Minimal metadata for an
ontology.
Metadata attributes
       IRI

Experimental metadata representation. Good science must
generate reproducible results271,272, and one aspect of reproducibility is the description of experimental methods and reagents
used to generate the reported outcomes. Researchers write the
protocols to standardize methods, to share their “know how”
with colleagues, and to facilitate the reproducibility of results.
Protocols typically specify a sequence of activities that may
involve equipment, reagents, critical steps, troubleshooting,
tips, and other essential information. Efforts such as CEDAR273
and ISA-Tools274 offer software and data standards to facilitate data collection, management, and reuse of experimental
metadata275. Ontologies such as the OBI, the SIO, and the ontology of scientific experiments (EXPO,276) offer vocabulary to
capture the design, execution and analysis of scientific experiments, including the protocols, materials used, and the data
generated.

       Namespace
       Title
       Description
       Format
       Contact
       Homepage
Versioning
       Version
       Previous version
       Number of active terms
       Number of obsolete terms
       Number of anonymous terms
Ontology structure
       Number of classes
       Number of children
       Number of property types
       Number of axioms
       Number of instances
       Maximum depth
       Maximum number of children

Table 3. Statistics from the EFO ontology
(OWL version of date: 7th September 2015)
parsed using a script in python developed
during BH15228.
Statistic

Count

Number of IDs

6032

Number of ID Names

6032

Number of obsolete IDs

772

Number of active IDs

5260

Number of EFO2UMLS mappings

55

Number of IDs with UMLS mapping

52

Number of IDs without UMLS mapping 5208

mappings. Other provenance maintaining approaches such as
Nanopublications269, singleton properties, or the Ontology of
Biomedical AssociatioNs (OBAN,270) that could be used to model
this metadata description at individual mapping level to enable
a more well detailed and fine-grained semantics description. Having good quality descriptions of ontology and mapping metadata is also relevant for ontology repositories such as BioPortal

The Experiment ACTions ontology (EXACT,277) suggests a
meta-language for the description of experiment actions and
their properties. The LABoratory Ontology for Robot Scientists
(LABORS,278) that addresses the problem of representing
the information required by robots to carry out experiments;
LABORS is an extension of EXPO and defines concepts such as
“investigation”, “study”, “test”, “trial” and “replicate”. Finally,
the SeMAntic RepresenTation for experimental Protocols ontology (SMART Protocols,279) is an application ontology designed
to describe an experimental protocol. The SMART Protocol
framework proposes a minimal information unit for experimental protocols; the Sample, Instrument, Reagent, Objective
model (SIRO, see 279), has been conceived in a way similar
to that of the Patient Intervention Comparison Outcome
(PICO,280) model. It reuses a number of existing ontologies
including the Information Artifact Ontology (IAO,281), the OBI,
the BioAssay Ontology (BAO,282), the Chemical Entities of
Biological Interest (ChEBI,283), the EFO, the Eagle-i Resource
Ontology (ERO,284), EXACT, and the NCBI taxonomy285.
Semantic Web technologies including ontologies and Linked
Data enable semantic publication of experimental protocols,
their classification, and the mining of textual descriptions
of experimental protocols.
Limitations of current approaches to experimental metadata
include an inability to cover the “digital continuum”—from
the highly diverse set of complex processes in laboratories to the needs expressed by regulatory affairs. There also
lacks a rapid mechanism to add new concepts into existing
ontologies and terminologies. Finally, experimental information
is often scattered over a complex network of applications ranging from Laboratory Information Management Systems (LIMS)
to text processors and Excel spreadsheets and, most of all,
laboratory notebooks. Researchers keep a detailed description of their daily activities, results, problems, plans, derivations
of the original plan, ideas, etc. in their laboratory notebooks.
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As a high-level abstraction serving to represent laboratory workflows, we argue, a General Process Model (GPM) is needed.
GPMs often represent a networked sequence of activities,
objects, transformations, and events that embody strategies
for accomplishing a specific task. Such models can be instantiated and specialized as needed. Figure 6 illustrates how a
GPM could be further instantiated. The model starts by defining actions in a laboratory. These should be generic so that
they can be made concrete as specifics from the laboratory are
added, e.g. properties, inputs, and outputs. These generic objects
can be linked in terms of inputs and outputs. Once there is an
abstract workflow, resources are then allocated. The execution
of the workflow instantiates all the properties for each object;
data is thus generated with rich, process-related metadata.
Repositories such as Dryad286, FigShare287, Dataverse288, and
many others structure metadata primarily for describing generic
attributes of the datasets while more specialized repositories such
as the Gene Expression Omnibus (GEO,289) or the PRoteomics IDEntifications database (PRIDE,290) capture specific elements of the experimental record. Our work to develop a GPM
will provide a basis by which published data, metadata, and the
experimental protocols used will establish a mechanism by
which researchers may execute data sharing plans that meet
the expectations of funders, journals and other researchers.
Knowledge graph annotation for human curation. Manual
curation of biomedical repositories is a well-established practice in the life sciences domain to improve the accuracy and reliability of data sources. An increasing number of repositories

is being made available as networks of concepts and relations,
i.e. “knowledge graphs”. Currently, a tool or data source that
exposes (part of) a knowledge graph typically provides an
annotation facility to allow curators (or the general public)
to make or suggest changes. However, such annotations are
often only used within the context of that particular tool, for
example to notify curators that there may be a problem with a
certain data entry, but frequently remain unusable and
undiscoverable for other purposes.
For this reason, we have developed a
Reusable Knowledge graph Annotator
a small, embeddable web service and
ture and publish an annotation event. A
like this:

tool called the Open,
(ORKA,291). ORKA is
user interface to captypical workflow looks

1. A
 user or curator of a graph-based resource wants to
report a defect or comment on a particular edge of the
graph.
2. T
 he resource provides a link that forwards the user to the
ORKA user interface.
3. T
 he user is identified by means of one of several open
authentication options.
4. T
 he user may now “edit” or comment on the particular
graph edge.
5. T
 he annotation is captured and stored and the user
will be redirected to the interface of the original resource.

Figure 6. From a General Process Model to an executable workflow.
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ORKA aims to support annotation from a wide range of data
sources and tools that are either based on or can be mapped
onto a knowledge graph. ORKA can be integrated with such
resources by enabling a request to its API. In a user interface this may look like an “Annotate now” link, button, or
context menu item, on an association or assertion from the
knowledge graph. The API requires minimally a pointer to the
original data source and the selected knowledge graph assertion specified as a single triple, i.e. RDF URIs for subject,
predicate and object. In subsequent steps, ORKA will collect
the identity of the user and record the annotation activity as a
self-contained, semantically interoperable digital object.
To identify the user, we envision a choice from a range of
commonly used open authentication identity providers. In
the current prototype, Open Researcher and Contributor ID
(ORCID) provides the main method of user authentication.
We consider the identity of the annotator to be an essential
part of the provenance of the annotation: firstly, it can be
used to rate or establish trust in the quality of a curator and,
secondly, it is needed to reward proper credit to the user for
their curation effort.
In the annotation stage, the user currently has the option to change
the relation, add a comment, or both. We found that offering
only a limited set of annotation options helps keep the annotation process quick and simple, yet still expressive. Through the
selection of an alternative relation, the user suggests an improvement that includes using a more specific predicate or negating
the relationship. Relations may be chosen from a pre-loaded set,
or from a specific ontology chosen by the user. The free
text box can be used to make any additional comments, and
currently also serves as a catchall to describe any other type of
annotation: for example, to support an assertion with additional
evidence, or when a suitable predicate is not readily available.
Finally, ORKA captures the annotation, including provenance
information (curator ID, date, original source triple and context), as a semantic digital object using the Nanopublication269
model and the Open Annotation ontology (OA,292). The annotation object is then stored in an annotation repository, which is
by default an open Nanopublication store (ORKA can also be
reconfigured to store to a private location). Subsequently, the
user has the option to browse the repository or return to the
original resource from which the annotation request to ORKA
was made. Meanwhile, the original data source will receive
a notification and link to the annotation object. Data sources
may then apply different strategies to incorporate the annotations in their resource: some may first want to perform manual validation, or choose to accept annotations from a selected
group of annotators automatically. We note that the semantic
description of the annotations and their provenance promotes
the reuse of annotations: third parties can access the (public)
annotation stores and use them for their own purpose. Attribution can be achieved, as Nanopublications are inherently
citable.
We have designed ORKA as a generic service to annotate different types of graph-based data sources and produce persistent,

reusable semantic digital annotation objects. During BH15 we
developed a browser bookmarklet that enables annotation of any
web page with embedded RDFa statements293. ORKA is currently
being developed in the context of the ODEX4All project294 to
enable annotation of its core knowledge platform. Initial use cases
have suggested a need for additional features, such as annotation of the object of a statement as well as specifying evidence
for an annotation (for example by citing published literature).
Supporting additional open authentication methods will lower
the entry barrier for potential users even further. In the future,
we hope to integrate ORKA in other resources and work
out scenarios to show how generically reusable annotations
result in richer, more accurate data sources and how this helps
knowledge discovery in the life sciences domain.

Conclusions
The BioHackathon series offers an unparalleled opportunity
for scientists and software developers to work together to tackle
challenging problems in the life sciences. BH15, the 2015
edition, was no exception, and featured contributions from a
wide range of subdisciplines.
On the topic of semantic metadata, we observed the FAIR principles gaining further traction with the development of additional tooling in the form of FAIR Projectors that represent data
in FAIR ways using a template-like system. Likewise pertaining to semantic metadata, work was done at BH15 to assess
the state of the art in recording the justification, provenance,
evidence, directionality and versioning of ontology mappings.
Additionally in this track, participants initiated work on a General Process Model to capture lab experimental metadata as networked sequences of activities, objects, transformations, and
events. Lastly in semantic metadata, participants worked on
the ORKA system for annotating knowledge graphs by human
curators. To contribute to the improvement of reproducibility in
bioinformatics, participants in that track worked on three technologies that formally represent the steps of in silico experiments and the computational environment in which such
experiments take place. The Common Workflow Language
(CWL) is a system to describe command line tools and chain them
together. At BH15, participants added CWL support to the Toil
workflow engine and worked on CWL components that consume JSON(-LD). In addition, the Docker lightweight system
for virtualization (‘containerization’) was targeted at BH15 to
enable discovery of bioinformatics containers and simplify
deployment of the Virtuoso triple store loaded with bioinformatic data sets. Lastly contributing to reproducibility, participants further extended the GNU Guix ecosystem, an alternative
approach for virtualization with certain security advantages,
by adding additional bioinformatics packages as well as
CWL and Ruby gems to it.
In the track on genotypes and phenotypes, participants worked
on the semantic representation of genotype and phenotype
data. This included the modeling of common, stably named and
canonically identifiable genomic variation as an RDF graph
that was queried using SPARQL. Conceptually related to this,
other participants worked on a real-time generated, queryable, semantic representation of VCF data, a commonly used
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format for representing variant calls such as SNPs. Contributing in this track to the semantic representation of phenotypes,
participants worked on the translation of the Human Phenotype
Ontology in Japanese. In efforts to contribute to the representation of comparative data within frameworks of shared evolutionary ancestry, participants in the orthology and phylogeny track
focused on two challenges. Firstly, work was done on the development of the Orthology Ontology to capture essential concepts pertaining to sequence orthology, including evolutionary
events such as sequence duplication and speciation. Secondly,
to attempt to place such evolutionary events on absolute time
scales, an evaluation was made of the amenability of the FossilCalibrations database on the semantic web by implementing a
prototype pipeline that calculates substitution rates for branches
between speciation events as a function of time since gene
duplication.
Contributing to semantic representations in chemistry, participants discussed strategies to advance cooperation between
chemical databases, including establishing agreement on which
database keys to use, how to make databases more interoperable by denser cross-referencing, and harmonizing RDF representations. Also in this track, more work was done on the PIERO
ontology for chemical transformations, including improved
RDF interoperability and additional data curation. An important
development was the definition of a classification based on
reaction characteristics. Moving on to larger molecules, in
proteomics, participants assessed the scalability of representing the UniProtKB database in OWL. Other participants in
the same track worked on ontologizing proteome data. An
important resource in this field is jPOST, for which an assessment of available controlled vocabularies and ontologies took
place and work on an RDF schema commenced. In glycomics,
participants worked on extending the development of an
ontology for representing glycan structures, GlycoRDF, which
was initiated at an earlier BioHackathon, in 2012.
In metabolomics, participants worked on improving the
availability on the semantic web of data pertaining to the
biochemical analysis of low-molecular-weight metabolites in
biological systems. This included a focus on the visualization
of plant metabolome profiles and the identification and annotation of metabolites. Participants in this track further worked
on the development of visual web applications to expose the
metabolome database AtMetExpress.
In the natural language processing track, participants worked
on the capture and analysis of human phenotype data from
free form text, i.e. the biomedical literature. Other participants in the same track worked on mining the structured text
from drug labels to collect rich representations of drug (side)
effects and indications. Also in this track, work was done on
data analytics on text-mined corpora, specifically to attempt to
learn associations between biological processes disrupted by
gene mutations with externalized phenotypes. Large assessments were made of the integration of text mined and curated
data and of the interoperability of disease terminology. As a
demonstration of the state of the art in generating natural

language, a demo was developed that generates a haiku from
data on the semantic web.
The data retrieval and query answering track was concerned
with new technologies for interrogating data on the semantic
web. This included exposing semantic web services for OpenLifeData through re-implemented, more scalable interfaces. Participants in this track also worked on the SPARQL Builder, a
tool for more easily constructing queries in the commonly used,
but not very user-friendly, SPARQL language. Other ways to
make queries easier included work on LODQA, a system that
constructs queries from natural language. A final demo of the
state of the art in interrogating the semantic web in a playful way was Crick-Chan, which presents itself through cartoon
animations and interacts with users through a chat bot interface.
BH15 thus contributed to many challenges in bioinformatics, including the representation, publication, integration and
application of biomedical data and metadata across multiple
disciplines including chemistry, biology, genomics, proteomics, glycomics, metabolomics, phylogeny and physiology.
A wealth of new semantics-aware applications have been developed through this hackathon that facilitate the reuse of complex
biomedical data and build on global efforts to develop an ecosystem of interoperable data and services. As requirements for
providing higher quality data and metadata continue to grow
worldwide, BioHackathon participants will be well positioned
to develop and apply semantic technologies to face the challenges
of tomorrow.
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This is a sprawling and fascinating report from a hackathon in 2015. The activities involve development of
software and standards across a broad range of subdisciplines within the life sciences, but are united by
largely basing their approaches on the application of semantic technologies. As such, the paper is an
excellent overview of a wide variety of ways in which semantic technologies are being employed with
great success in the biological sciences. Areas targeted include genotype/phenotype data, orthology and
phylogeny, proteomics, metabolomics, data retrieval and querying, natural language processing,
reproducibility, and metadata representation. Despite the several years that have elapsed since then,
many of the tools built and insights gleaned still have relevance today, and so we are grateful that this
work has been written and published. However, we believe that this five year gap between event and
publication provides a valuable opportunity for the authors to reflect on how that hackathon work was
useful, both in its original context as well as today. We think the authors did an excellent job describing
this in the section “Assessing the Findable, Accessible, Interoperable, and Reusable Principles”, but
some other sections suffer by not being clear about what was developed before, during and after the
hackathon. It may turn out that some of this work was not particularly useful in the long term — which is
only to be expected in a hackathon — but it might also be that a good idea from five years ago has been
subsequently overlooked, and this work might be in a position to call attention to such ideas.
Having explicit subsections entitled “Changes in the landscape since 2015” in every section could be
helpful in making this clearer. There are also several references to events that were contemporaneous
with the hackathon; for example, in the section “Molecular evolutionary process calibration”, the authors
write that “Recently, a working group at the National Evolutionary Synthesis Center (NESCent) …”.
However, this is incorrect to state in a document published in 2020, as NESCent was shut down in June
2015. Clarifying which parts of the text are true as of the workshop and which are true today would help to
prevent such errors.
Understandably for activities at a hackathon, some activities could be described in a little more detail,
while some descriptions could be more concise. Some notes on the various descriptions follow:
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Variation graph construction:
It would be helpful to state which triplestore database was used when stating performance results.
Orthology ontology development and application:
Grammatical issue in sentence including “Although the standard mapping and transformation by
SWIT was largely able to transform the content of the three databases, though a few
resource-specific rules were necessary because” (remove ‘though’?).
Molecular evolutionary process calibration:
The authors point out that a particular JSON resource is “convenient for programmers but it also
means that certain concepts used in the JSON are ambiguous as they are not linked to any
controlled vocabulary or ontology.” They should mention JSON-LD as a possible solution to this
problem, a technology they refer to several times elsewhere in the paper.
Protein semantic representation:
It would be useful to include a brief statement about how the particular axiomatization described
supports some use cases. Besides OWL 2 EL scalability, what motivated this particular design?
"For complex datasets, the additional semantics of OWL, which includes assertions of disjointness,
i.e. the explicit semantic distinction between classes and their instances, and axioms restricting the
use of classes and object properties, may be particularly beneficial." Here, it seems like an
inaccurate definition is provided for ‘disjointness’ (“explicit semantic distinction between classes
and their instance”). This is not what disjointness means, but perhaps this was just meant to be a
list of logical features provided by OWL. Remove ‘i.e.’?
A layout issue we noted was the sentence “We also generate the following axioms (here
expressed in Manchester OWL Syntax)”, which should not be a bullet point.
Tools for metabolite identification and interpretation / Plant metabolome database development:
These sections provide a large amount of background information, taking longer to reach the
description of what was accomplished at the hackathon.
Chemical database integration:
Perhaps it wasn't discussed at the hackathon, but we are curious how the ChEBI ontology fits into
this picture of harmonization across chemical databases.
Clinical phenotype text mining:
The superscript citation format makes some of the sentences oddly worded (e.g., second
paragraph) where it seems like the author name is meant to be in the sentence. "For example 160,
assessed the contribution of …”. In this case, it appears that the citation was intended to be
included inline, i.e. “For example, Kotfila and Uzuner (2005) assessed ...”. In these cases, the text
should be rewritten so that it is easier to read.
The abbreviation section could benefit from hyperlinks to the ontologies (and possibly also the
organizations) being linked to.
Apart from these relatively minor issues, we are grateful that the authors have published this work and
recorded the activities at what appears to be a wide-ranging and productive hackathon. Also,
congratulations to them on producing the first semantic haiku!
Is the topic of the opinion article discussed accurately in the context of the current literature?
Partly
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Partly
Are all factual statements correct and adequately supported by citations?
Yes
Are arguments sufficiently supported by evidence from the published literature?
Yes
Are the conclusions drawn balanced and justified on the basis of the presented arguments?
Yes
Competing Interests: James Balhoff would like to note a non-financial competing interest: co-authorship
of two articles [1,2] within the last three years with one of the authors (Dr. Tudor Groza). I and Dr. Groza
both contribute to the Monarch Initiative, but do not directly collaborate. I confirm that this competing
interest hasn't affected my ability to write an objective and unbiased review of the article. [1]
https://academic.oup.com/nar/article/47/D1/D1018/5198478 [2]
https://academic.oup.com/nar/article/45/D1/D712/2605791
Reviewer Expertise: semantic technologies, bio-ontologies, bioinformatics
We confirm that we have read this submission and believe that we have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
Reviewer Report 31 March 2020

https://doi.org/10.5256/f1000research.19948.r60449
© 2020 Frey J. This is an open access peer review report distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.

Jeremy G. Frey
School of Chemistry, Faculty of Engineering and Physical Sciences, University of Southampton,
Southampton, UK
This is a well written report of a Hackathon activity in the area of semantics and ontologies for life
sciences with a view to using these semantic technologies and knowledge structures to enhance the
reproducibility and I would say the use and re-use of life sciences data and methods in a number of
typically gene and protein related areas. While the report is on an activity which I presume took place in
2015 the material is very relevant and not dated.
The report contains very good summaries of the prior art on the areas, especially ontologies that cover the
areas of interest and are of potential use across the whole of the scientific research life cycle. The details
of the challenges, data made available, teams and goals are provided and will benefit the community
though it will need detailed reading to absorb the extensive material provided by the authors. The
extensive references are themselves a very useful research source.

I consider this to be a well written and useful contribution to the literature which will help the community in
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I consider this to be a well written and useful contribution to the literature which will help the community in
building new and useable systems (and also not to re-invent things that do already work).
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